Our Development Pipeline
First-In-Class Small Molecule Modulator of Neutrophil Trafficking and Activation
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
ADS051
Portfolio of First-In-Class Small Molecule Inhibitors of the NLRP3 and 1 Inflammasomes
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
ADS032